Azenta Inc (AZTA)
45.53
+0.88
(+1.97%)
USD |
NASDAQ |
Nov 21, 16:00
44.51
-1.02
(-2.24%)
Pre-Market: 09:26
Azenta Enterprise Value: 1.613B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.613B |
| November 20, 2024 | 1.573B |
| November 19, 2024 | 1.402B |
| November 18, 2024 | 1.378B |
| November 15, 2024 | 1.430B |
| November 14, 2024 | 1.480B |
| November 13, 2024 | 1.566B |
| November 12, 2024 | 1.634B |
| November 11, 2024 | 1.627B |
| November 08, 2024 | 1.579B |
| November 07, 2024 | 1.611B |
| November 06, 2024 | 1.658B |
| November 05, 2024 | 1.642B |
| November 04, 2024 | 1.584B |
| November 01, 2024 | 1.416B |
| October 31, 2024 | 1.410B |
| October 30, 2024 | 1.457B |
| October 29, 2024 | 1.442B |
| October 28, 2024 | 1.448B |
| October 25, 2024 | 1.400B |
| October 24, 2024 | 1.398B |
| October 23, 2024 | 1.430B |
| October 22, 2024 | 1.527B |
| October 21, 2024 | 1.531B |
| October 18, 2024 | 1.549B |
| Date | Value |
|---|---|
| October 17, 2024 | 1.521B |
| October 16, 2024 | 1.542B |
| October 15, 2024 | 1.589B |
| October 14, 2024 | 1.612B |
| October 11, 2024 | 1.602B |
| October 10, 2024 | 1.561B |
| October 09, 2024 | 1.569B |
| October 08, 2024 | 1.620B |
| October 07, 2024 | 1.692B |
| October 04, 2024 | 1.738B |
| October 03, 2024 | 1.700B |
| October 02, 2024 | 1.713B |
| October 01, 2024 | 1.702B |
| September 30, 2024 | 1.745B |
| September 27, 2024 | 1.820B |
| September 26, 2024 | 1.810B |
| September 25, 2024 | 1.693B |
| September 24, 2024 | 1.800B |
| September 23, 2024 | 1.805B |
| September 20, 2024 | 1.814B |
| September 19, 2024 | 1.825B |
| September 18, 2024 | 1.817B |
| September 17, 2024 | 1.805B |
| September 16, 2024 | 1.754B |
| September 13, 2024 | 1.778B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.073B
Minimum
Sep 27 2022
9.052B
Maximum
Nov 08 2021
3.501B
Average
2.699B
Median
Feb 02 2024
Enterprise Value Benchmarks
| Bruker Corp | 10.71B |
| Harvard Bioscience Inc | 127.50M |
| Bionano Genomics Inc | 14.35M |
| Akoya Biosciences Inc | 145.08M |
| Singular Genomics Systems Inc | -53.66M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.984M |
| Revenue (Quarterly) | 170.06M |
| Total Expenses (Quarterly) | 181.08M |
| EPS Diluted (Quarterly) | -0.10 |
| Gross Profit Margin (Quarterly) | 40.82% |
| Profit Margin (Quarterly) | -2.93% |
| Earnings Yield | -6.52% |
| Normalized Earnings Yield | -1.484 |